Matthew Reynolds
Neurological Surgery · Maywood, ILNPI 1811150394
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,325 of the $3,753 with a category attached, or 88.6%. Boston Scientific accounts for 88.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $3,350 and has fallen 93.9% since, to $205 in 2025.
Across 13 payments — averaging $288.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Stryker$158
- Kerecis Limited$144
- Orthofix Medical, Inc.$65
- Johnson & Johnson$25
- Kestra Medical Technology Services, Inc.$23
- plus $13 from 1 others
What the payments were for
- Consulting fees$3,32589%
- Food & beverage$42811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $3,325 |
| Stryker | 2 | $158 |
| Kerecis Limited | 1 | $144 |
| Orthofix Medical, Inc. | 4 | $65 |
| Johnson & Johnson | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| Kls-martin L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CROSSBOSS$3,325
- Kerecis SurgiClose$575
- Kerecis GraftGuide$144
- SURPASS EVOLVE$122
How this compares
$3,753 in reported general payments places this provider in the 55th percentile of 302 neurological surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $285 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Maywood
- Suguna PappuMaywood$32K
- Tyler KoskiChicago$2.3M
- Vincent TraynelisChicago$1.8M
- Sergey NeckryshChicago$1.6M
- Russell NockelsArlington Heights$1.4M
- Bruce FrankelSpringfield$1.3M
- Richard FesslerChicago$910K
- Julian BailesEvanston$666K
- John OtooleChicago$593K
- Patrick SugruePark Ridge$571K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.